ArticleBlood advances2025

Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR.

Kitsada Wudhikarn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.